29/04/2024 - Annovis Bio Inc.: April 29, 2024Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease

The text version of this document is not available. You can access the original document here.

Attachments

• Original Link
• Permalink

Disclaimer

Annovis Bio Inc. published this content on 29 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 April 2024 14:18:18 UTC.